ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy

A multi-center imaging trial by the American College of Radiology Imaging Network (ACRIN) “A Multicenter, phase II assessment of tumor hypoxia in glioblastoma using (18)F Fluoromisonidazole (FMISO) with PET and MRI (ACRIN 6684)”, was conducted to assess hypoxia in patients with glioblastoma (GBM). T...

Descripción completa

Detalles Bibliográficos
Autores principales: Ratai, Eva-Maria, Zhang, Zheng, Fink, James, Muzi, Mark, Hanna, Lucy, Greco, Erin, Richards, Todd, Kim, Daniel, Andronesi, Ovidiu C., Mintz, Akiva, Kostakoglu, Lale, Prah, Melissa, Ellingson, Benjamin, Schmainda, Kathleen, Sorensen, Gregory, Barboriak, Daniel, Mankoff, David, Gerstner, Elizabeth R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002091/
https://www.ncbi.nlm.nih.gov/pubmed/29902200
http://dx.doi.org/10.1371/journal.pone.0198548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002091/
https://www.ncbi.nlm.nih.gov/pubmed/29902200
http://dx.doi.org/10.1371/journal.pone.0198548

Ejemplares similares